Description: BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010. Missioned by social responsibility of humanity needs, we develop advance technologies to provide reliable, accurate and high-quality products and fast response to any infectious diseases globally.
manufacturer (4485) solution (2340) diagnostics (1104) biotechnology (814) integrated (401) bioperfectus (2) invitrodiagnostics diseasecontrol moleculardiagnostics pcrmanufacturer
(SSE:688399)
Since its founding in 2010, BioPerfectus has been dedicated to providing molecular diagnostic solutions specializing in emerging infectious diseases for generations and generations to come. We are leading the change by offering Real-Time PCR Kits, Nucleic Acid Extraction Systems, Automation Solutions, and Rapid Tests to laboratories, hospitals, institutions, and CDCs across the globe. BioPerfectus products have been distributed to more than 100 countries around the world. As one of the leading global IVD su
An industrial park of over 62,000㎡ integrating fully self-innovative R&D, production, warehousing, logistics, sales, marketing and customer service divisions catering for various business scenarios